Intervention

musculoskeletal complications management/prevention

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2
Recruiting0
Common conditions25
Lead sponsors shown2
Advertisement

Common conditions

Stage IIIA Breast Cancer2Stage IIIB Breast Cancer2Stage IIIC Breast Cancer2Accelerated Phase Chronic Myelogenous Leukemia1Adult Acute Lymphoblastic Leukemia in Remission1Adult Acute Myeloid Leukemia in Remission1Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities1Adult Acute Myeloid Leukemia With Del(5q)1Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)1Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)1Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)1Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)1Arthralgia1Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative1Blastic Phase Chronic Myelogenous Leukemia1Chronic Eosinophilic Leukemia1Chronic Myelomonocytic Leukemia1Chronic Neutrophilic Leukemia1Chronic Phase Chronic Myelogenous Leukemia1de Novo Myelodysplastic Syndromes1Disseminated Neuroblastoma1Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue1Musculoskeletal Complications1Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable1Nodal Marginal Zone B-cell Lymphoma1

Trial status mix

COMPLETED1
WITHDRAWN1

Phase mix

NA1
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.